Embla Medical hf. (OSSUY)
OTCMKTS · Delayed Price · Currency is USD
4.000
-0.480 (-10.71%)
At close: May 8, 2025
Embla Medical Market Cap
Embla Medical has a market cap or net worth of $1.97 billion as of September 12, 2025. Its market cap has increased by 2.54% in one year.
Market Cap
1.97B
Enterprise Value
2.45B
Revenue
873.51M
Ranking
n/a
PE Ratio
26.96
Stock Price
$4.00
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 444.74M to 1.97B, an increase of 343.35%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.97B | -6.78% |
| Dec 30, 2024 | 2.12B | 23.63% |
| Dec 29, 2023 | 1.71B | -15.52% |
| Dec 30, 2022 | 2.03B | -25.54% |
| Dec 30, 2021 | 2.72B | -19.43% |
| Dec 30, 2020 | 3.38B | 1.84% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 585.86M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |